
Veeda Clinical Research Limited
vs. prev. close ₹420
52W High
₹420
52W Low
₹415
Price History
52W High
₹420
52W Low
₹415
About Veeda Clinical Research Limited
Get the latest Veeda Clinical Research unlisted share price. Buy or sell Veeda Clinical Research with ease, stay updated with UnlistedZone.
About the Company Veeda Clinical Research Limited is one of the largest independent full-service clinical research organizations (CRO) in India. Established in 2004, the company has grown significantly, providing a broad range of clinical research solutions to the pharmaceutical industry globally. Business Model Veeda operates on a comprehensive business model offering end-to-end clinical research services, including pre-clinical, early phase, and late phase clinical trials. The company's approach is designed to deliver cost-effective and timely research solutions to pharmaceutical companies, thereby aiding in the development and launch of new drugs. Services Veeda offers a wide array of services that cover most aspects of drug development and launch. These include: Bioavailability and Bioequivalence (BA & BE) Studies: Specialized services to determine the pharmacokinetic properties of drugs. Pre-Clinical and Clinical Trials: Comprehensive services for conducting pre-clinical, Phase I, Phase II, and Phase III trials. Bioanalytical Services: Advanced bioanalytical research capabilities to support drug development. Pharmacovigilance: Safety monitoring and regulatory compliance services. Medical Writing: Preparation of essential study documents in line with regulatory requirements. Industry Trend The global CRO market is projected to grow significantly, driven by increasing pharmaceutical R&D expenditures and the outsourcing trend among pharmaceutical companies to reduce costs and expedite drug development. Veeda is well-positioned to capitalize on these trends with its extensive service offerings and strong regulatory compliance record. Branches and Research Facilities: Veeda has expanded its infrastructure to include multiple facilities: Ahmedabad: Four facilities with a total capacity of 532 beds and advanced bioanalytical laboratories. Mehsana: One clinical facility. Bangalore: Two pre-clinical facilities acquired through Bioneeds, featuring 99 exclusive experimen
Company Details
Industry
Pharmaceuticals
Founded
2004
Headquarters
Ahmedabad, Gujarat, India
Min Lot Size
1
Face Value
₹2.00
Total Shares
69858503
Regulatory Information
Corporate Identity Number (CIN)
U73100GJ2004PLC044023
PAN Number
AACCC3633Q
ISIN
INE01HQ01026
Key Valuation Ratios
Valuation
Market Cap
₹2,934.06 Cr
P/E Ratio
—
Not meaningful — loss-making
P/S Ratio
4.10×
P/B Ratio
2.62×
EV / EBITDA
14.12×
Returns & Per Share
ROE
-1.25%
EPS
₹-2.01
Book Value / Share
₹160.39
Solvency
Debt / Equity
0.38×
Interest Coverage
1.12×
Company Fundamentals
As of FY2026 Annual · updated 07 Sept 2026Gross Profit
₹677.93 Cr
EBITDA
₹226.27 Cr
Revenue Growth
17.35%
Profit Margin
-1.96%
Express buy interest
No commitment — the desk will reach out
Current Price
₹420Secure & Verified Transaction
Unlisted shares are illiquid and carry higher market risks. Please read the Risk Disclosure before investing.
Talk to a Specialist
Get expert guidance on this investment